NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

Avalyn Pharma Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERAVLN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / AVLN COVERAGE

What’s moving Avalyn Pharma Inc. now

Current reporting with the operating signal separated from the noise.

01
Avalyn Pharma Inc.(NasdaqGS:AVLN) added to S&P Pharmaceuticals Select Industry Index

Avalyn Pharma Inc.(NasdaqGS:AVLN) added to S&P Pharmaceuticals Select Industry Index

The story matters when it changes Avalyn Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Avalyn Pharma Inc.: Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors

Avalyn Pharma Inc.: Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors

The story matters when it changes Avalyn Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Avalyn Pharma Inc. (AVLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Avalyn Pharma Inc. (AVLN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

The story matters when it changes Avalyn Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Avalyn Pharma Inc.

Avalyn Pharma Inc.

The story matters when it changes Avalyn Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Avalyn Pharma Inc. (AVLN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Avalyn Pharma Inc. (AVLN) Presents at Jefferies Global Healthcare Conference 2026 Transcript

The story matters when it changes Avalyn Pharma Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
Avalyn Pharma Inc. Common Stock (AVLN) Institutional Holdings

Avalyn Pharma Inc. Common Stock (AVLN) Institutional Holdings

Investors are testing whether Avalyn Pharma Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest AVLN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-12 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-06-03 · Period 2026-03-31SEC ↗8-KMaterial company eventFiled 2026-09-16 · Period 2026-09-15SEC ↗8-KMaterial company eventFiled 2026-08-12 · Period 2026-08-12SEC ↗8-KMaterial company eventFiled 2026-07-01 · Period 2026-06-29SEC ↗4Official SEC filingFiled 2026-09-17 · Period 2026-09-15SEC ↗3Official SEC filingFiled 2026-09-17 · Period 2026-09-15SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-08-14SEC ↗
EARNINGS / QUARTERLY TRACKER

Avalyn Pharma Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.